Interestingly, RBBP4, a downstream regulator of RB1, is upregulated by RB1 mutation [36] and enhances mesenchymal marker expression in human cervical and colon cancer cell lines [37,38]. Here, RBBP4 is linked to malignant colon neoplasm.